- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06213207
Cluster Randomized Controlled Trial Applying Helping Baby Breathe in Nepal (SaLiN)
Saving Lives of Newborn (SaLiN): A Cluster Randomized Controlled Trial Applying Helping Baby Breathe to Manage Birth Asphyxia in Sarlahi District of Madhesh Province, Nepal
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Khem N Pokhrel, PhD
- Phone Number: 9851113827
- Email: pratikjee@gmail.com
Study Contact Backup
- Name: Amrendra Ray, MPH
Study Locations
-
-
-
Lalitpur, Nepal
- Recruiting
- Development and Research Service International Nepal
-
Contact:
- Amrendra Ray, MPH
-
Contact:
- Khem Narayan Pokhrel, PhD
- Phone Number: 9851113827
- Email: pratikjee@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria
Health service providers those are directly involved in providing newborn care services
Have received Community-based Integrated Management of Neonatal and Childhood Illness (CB-IMNCI) training Have worked in the study facilities at least one year
Exclusion Criteria:
Health workers, Those lack experience at least six months of working in birthing centers Those who does not qualify as skilled birth attendant (non-SBA) Those who received training already
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Newborn care service providers with simulation-based training and newborns
Newborn care providers will be the subject for receiving intervention.
The will receive 5 days training on managing essential newborn care and birth asphyxia using neonatalie.
The service providers will be provided monthly mentoring and coaching.
The newborn who receive the services
|
The intervention, HBB training package will be used which was applied to train the hospitals staff in Nepal (Chaulagain et al., 2021) and Laerdal Global Health (Laerdal Global Health, 2021) to enhance the competencies on the resuscitation to newborn using NeoNatalie.
Health workers will receive 5 days simulation training by expert pediatrician and pediatric nurse who have prior working experience in Neonatal Intensive Care Unit (NICU) or Special Neonatal Care Unit.
After the training, mentoring and coaching will be provided experienced newborn coach/trainer on a monthly basis for six months.
|
No Intervention: Controlled health facilities with newborn care service providers with no training and newborns
The newborn care providers from control health facilities will not receive any additional training.
They provide usual services.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Skill performance of the newborn care provider
Time Frame: six months
|
The skill performance of the newborn care providers covering all nine components of essential newborn care.
Their skills related to resuscitation procedures will be measured using skill inventory.
|
six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neonatal health outcomes
Time Frame: six months
|
Neonatal health outcomes is measured as neonates who received services for asphyxia management and other essential newborn care
|
six months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Santosh Adhikari, MD, Kanti Children's Hospital, Kathmandu
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NP593-2023
- 2023-0091 (Laerdal Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Newborn Morbidity
-
Assumpta Solome NantumeDLR German Aerospace Center; Academic Model Providing Access to Healthcare...RecruitingNewborn Morbidity | Newborn ComplicationKenya
-
University of Alabama at BirminghamCompletedNewborn MorbidityUnited States
-
Universidad Autonoma de Nuevo LeonCompletedHospital Readmission | Newborn Morbidity | Newborn | Newborn Complication
-
Julie LefevereCompletedNewborn MorbidityBelgium
-
Hacettepe UniversityCompletedSurgery--Complications | Newborn Morbidity | Neonatal SurgeryTurkey
-
Universidad de la SabanaNot yet recruitingTelemedicine | Newborn Morbidity | Simulation Training | Assessment, SelfColombia
-
Aga Khan UniversityBill and Melinda Gates FoundationCompleted
-
Mayo ClinicEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingMorbidity;Newborn | Death; NeonatalUnited States
-
Universidade Metodista de PiracicabaRecruiting
-
Benha UniversityCompletedNewborn Morbidity | Anesthesia; Adverse EffectEgypt